Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine TNF superfamily member 14 (TNFSF14) ELISA Kit-Sandwich

Name: Canine TNF superfamily member 14 (TNFSF14) ELISA Kit-Sandwich
SKU: EK10F621
Rating: 5 (1 reviews)

Cat. No.EK10F621

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Canine TNFSF14 ELISA Kit-Sandwich is designed for the quantitative determination of Canine TNFSF14 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine TNFSF14.

Target Species Canine

Species Reactivity Canine

Detection Range 32-2000 pg/mL

Sensitivity 6.25 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

TNF superfamily member 14 is encoded by the TNFSF14 gene in dogs. It is consistent with pro-inflammatory immune responses.

Target/Biomarker Canine TNFSF14

Target Synonym TNF superfamily member 14; LIGHT; TNLG1D; tumor necrosis factor ligand superfamily member 14; tumor necrosis factor ligand 1D; tumor necrosis factor superfamily member 14

Gene ID 611306

UniProt ID A0A8C0P717

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Boss, M. K. et al. Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research. Frontiers in oncology. 2022, 12: 1033704.